Physical inactivity of murine retrovirus infected C57BL/6 mice is prevented by melatonin and dehydroepiandrosterone

Proceedings of the Society for Experimental Biology and Medicine

Volumn 219, Issue 2, 1998, Pages 144-148

  Araghi Niknam, Mohsen ^a   Lane, Lisa ^a   Watson, Ronald R ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN; PRASTERONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DIET SUPPLEMENTATION; HORMONAL REGULATION; IMMUNE RESPONSE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHYSICAL ACTIVITY; RETROVIRUS; VIRUS INFECTION;

ANIMALIA; MURINAE; UNIDENTIFIED RETROVIRUS;

EID: 0031671471     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-219-44327     Document Type: Conference Paper

References (38)

1. Berkman LF, Seeman TE, Albert M. High, usual and impaired functioning in community-dwelling older men and women: Findings from the MacCarthy Foundation Research Network on Successful Aging. J Clin Epidemiol 46:1129-1140, 1993.
2. Araneo BA, Woods ML, Daynes RA. Reversal of the immunosenescence phenotype by dehydroepiandrosterone: Hormone treatment provides an adjuvant effect on the immunization of aged mice with recombinant hepatitis B surface antigen. J Infec Dis 167:830-840, 1993.
3. Watson RR, Huls A, Araghi-Niknam M. Dehydroepiandrosterone and diseases of aging. Drugs Aging 9:274-291, 1996.
4. Sei Y, Paul Arora PK, Skolnik P, Paul IA. Spatial learning impairment in a murine model of AIDS. J Immunol 142:1144-1149, 1992.
5. Macallan DC, Noble C, Baldwin C, Jebb SA, Prentice AM, Coward WA, Sawyer MB, McManus TJ, Griffin GE. Energy expenditure and wasting in human immunodeficiency virus infection. N Engl J Med 333:83-88, 1995.
6. Melchior CL, Ritzman RF. DHEA is an anxiolytic in mice on the plus maze. Biochem Behav 47:437-441, 1994.
7. Nunez EA, Christeff N. Steroid hormone, cytokine, lipid and metabolic disturbances in HIV infection. Baillieres Clin Endocrinol Metab 8:803-824, 1994.
8. Kochakian CD. Mechanism of anabolic action of androgens. Acta Endocrinol Suppl 92:192-213, 1964.
9. Barrett-Connor E, Khaw K, Yen SC. A prospective study of DS, mortality and cardiovascular disease. N Engl J Med 315:1519-1524, 1986.
10. Helzlsouer KJ, Gordon GB, Alberg A. Relationship of prediagnostic serum levels of DHEA and DHEAS to the risk of developing pre-menopausal breast cancer. Cancer Res 52:1-1, 1992.
11. Thoman ML, Weigle WO. The cellular and subcellular bases of immunosenescence. Adv Immunol 46:221-2261, 1989.
12. Araghi-Niknam M, Liang B, Zhen Z, Watson RR. Modulation of immune dysfunction during murine leukemia retrovirus infection of old mice by dehydroepiandrosterone sulfate (DHEAS). Immunology 90:443-149, 1997.
13. Araghi-Niknam M, Chung S, Nelson-White T, Watson RR. Antioxidant activity of dioscorea and dehydroepiandrosterone (DHEA) in older humans. Life Sci 59:133-139, 1996.
14. Christeff N, Gherib N, Mammes O, Dale MT, Gharakhanian S, Lortholary O, Melchior JC, Nunez AE. Serum DHEA concentration during HIV infection. Psychoneuroendocrinology 22:S11-S18, 1997.
15. Araghi-Niknam M, Zhen Z, Liang B, Watson RR. Cytokine dysregulation and increased oxidation prevented by dehydroepiandrosterone in mice infected by marine leukemia retrovirus. Proc Soc Exp Biol Med 216:386-391, 1997.
16. Watson RR. Murine models for acquired deficiency syndrome. Life Sei 44:i-xii, 1989.
17. Zhang Z, Araghi-Niknam M, Liang B, Inserra P, Ardestani SK, Jiang S, Chow S, Watson RR. Prevention of immune dysfunction and vitamin E loss by dehydroepiandrosterone and melatonin supplementation during murine retrovirus supplementation. Immunology (in press) 1998.
18. Davies AM, Parker LA. Fenfluramine-induced place aversion in a three choice apparatus. Pharmacol Biochem Behav 44:595-600, 1993.
19. Sei Y, Arora PK, Layer RT, Hartley JW, Morse HC, Skolnic P, Heys MP. Quinolinic acid levels in a murine retrovirus-induced immunodeficiency syndrome. J Neurochem 66:296-302, 1997.
20. Duncan DB. Multiple range F test. Biometrics XV1:1-42, 1966.
21. English AE, Hemphil MK, Paul IA. LPB-M5 infection impairs acquisition, but not performance, of active avoidance responding in C57BL/6 mice. FASEB J 12:175-179, 1998.
22. Nishida K, Marks SP, Kusove Y, Morse HC, Skolnic P, Basil AS, Sei Y. Increased brain levels of factor in murine acquired immunodeficiency model are NMDA receptor mediated. J Neurochem 66:433-435, 1996.
23. Dollins AB, Lynch HJ, Wurtman RJ. Effect of pharmacological day-time doses of melatonin on human mood and performance. Psychopharmacol Bull 112:490-496, 1993.
24. Guardiola-Lemaitre B, Lenegre A, Porsolt RD. Combined effects of diazepam and melatonin in two tests for anxiolytic activity in the mouse. Pharmacol Biochem Behav 41:405-408, 1992.
25. Lissoni P, Vigore L, Rescaldani R, Rovelli F, Giani L, Barni S, Tancini G, Ardizzoia A, Vigani MG. Neuroimmunology with low dose subcutaneous IL-2 plus melatonin in AIDS patients with CD4 numbers below 200/mm 3: A Biological phase-II study. J Biol Regul Homeost Agents 9:155-158, 1995.
26. Laughlin GA, Lauks AB, Yen SS. Marked augmentation of nocturnal melatonin secretion in amenorrheic athletes, but not in cycling athletes: Unaltered by opioidergic or dopaminergic blockade. J Clin Endocrinol Metab 73:1321-1326, 1991.
27. Monteleone P, Fuschino A, Nofe G. Temporal relationship between melatonin and cortisol responses to night time physical stress in humans. Psychoneuroendocrinology 17:81-86, 1992.
28. Monteleone P, Maj M, Fuschino A. Physical stress in the middle of the dark phase does not affect light-depressed plasma melatonin levels in humans. Neuroendocrinology 55:367-371, 1992.
29. Whichmann MW, Demaso ZR, Ayala R, Chaudry IH. Melatonin administration attenuates depressed immune dysfunction trauma-hemorrhage. J Surg Res 63:256-262, 1996.
30. Centurelli MA, Abate MA. The role of dehydroepiandrosterone in AIDS. Ann Pharmacotherapy 31:639-642, 1997.
31. Yung YJ, Schwanz A, Henderson EE. Inhibition of HIV-1 latency reactivation by DHEA and analog of DHEA. AIDS Res Hum Retroviruses 9:747-753, 1993.
32. Clerici MA, Abate MA. The role of dehydroepiandrosterone in AIDS. Ann Pharmacother 31:639-642, 1997.
33. Liang B, Wang JY, Watson RR. Murine AIDS a key to understanding retrovirus-induced immunodeficiency. Viral Immunol 98:225-239, 1996.
34. Tisdale MJ. Newly identified factors that alter host metabolism in cancer cachexia. Trends Pharmacol Sci 11:473-475, 1990.
35. Pekala PH, Price SR, Horn CA. Selective inhibition of synthesis of enzymes for de novo fatty acid biosynthesis by an endotoxin-induced mediator from exudate cells. Proc Natl Acad Sci USA 80:2743-2747, 1983.
36. Garcia-Martinez C, Lopez-Soriano FJ. Acute treatment with tumor necrosis factor-x induces changes in protein metabolism in rat skeletal muscle. Mol Cell Biochem 125:11-18, 1993.
37. Araghi-Niknam M, Ardestani SK, Molitar M, Inserra P, Eskelson CD, Watson RR. Dehydroepiandrosterone (DHEA) sulfate prevents reduction in tissue vitamin E and increased lipid peroxidation due to murine retrovirus infection of aged mice. Proc Soc Exp Biol Med 218:210-217, 1998.
38. Homo-Delarche F. Glucocorticoids, lymphokine and the cell response. Progress In: Endocrinology. Amsterdam: Elsevier, pp 349-354, 1987.